Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1230957

registered interest
date	02/09/2020
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Roads: Construction
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to review their process of assessing (1) the carbon emissions, and (2) the economic benefits, resulting from new roadbuilding schemes; and what consideration they have given to assessing those impacts against the same criteria.
tabling member printed	Baroness Bennett of Manor Castle
uin	HL7600
answer	answer is ministerial correction date of answer 15/09/2020 answer text <p>Her Majesty’s Government employs a relevant, robust and trusted analytical process designed to assess the likely impacts of both individual strategic road schemes and our road investment strategy as a whole. The impacts of such schemes on, for example, carbon, employment, housing, air quality and environmental issues are all assessed by the Department in line with its Transport Analysis Guidance (TAG).</p><p> </p><p>The Department keeps its appraisal and modelling methodologies which are set out in TAG, under constant review, commissioning research to improve the evidence base as well as improving methodologies. The recently published TAG route map sets out our plans to update our guidance over the next six months and includes plans to update carbon values once these are finalised by the Department of Business, Energy and Industrial Strategy (BEIS).</p><p> </p> answering member printed Baroness Vere of Norbiton question first answered 15/09/2020 11:55:12 answering member 4580 label Biography information for Baroness Vere of Norbiton
tabling member	4719 label Biography information for Baroness Bennett of Manor Castle

899937

registered interest
date	08/05/2018
answering body	Ministry of Justice
answering dept id	54
answering dept short name	Justice
answering dept sort name	Justice
hansard heading	Slavery: Sentencing
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many appeals against sentence there have been under section 2 of the Modern Slavery Act 2015.
tabling member printed	Baroness Doocey
uin	HL7600
answer	answer is ministerial correction date of answer 22/05/2018 answer text <p>In 2015 and 2016 there were no convictions under Sections 1 or 2 of the Modern Slavery Act 2015 reported to the Ministry of Justice. In 2017, a total of 7 offenders were convicted of offences under Section 1 of the Modern Slavery Act 2015 and 8 offenders were convicted of offences under Section 2 of the Act.</p><p> </p><p>Recorded figures relate to persons for whom these offences were the principal offences for which they were dealt with. When a defendant has been found guilty of two or more offences the principal offence is the offence for which the heaviest penalty is imposed. Where the same disposal is imposed for two or more offences, the principal offence recorded is the offence for which the statutory maximum penalty is the most severe.</p><p> </p><p>The figures appearing in the Written Answer of 30 April [HL6886 and HL 6887] were taken from the Crown Court case management system and provided a total of appeals initially lodged but not at the point of being categorised by appeal type. Consequently, these figures included cases that the Criminal Appeal Office would later have recorded as appeals against other offences. Figures taken from Criminal Appeal Office records, which do categorise appeal types, show that:</p><p> </p><p> </p><p>No applications for leave to appeal against conviction under section 1 of the Modern Slavery Act have been received.</p><p> </p><p>1 application for leave to appeal against conviction under section 2 of the Modern Slavery Act has been received and is still pending.</p><p> </p><p>1 application for leave to appeal against sentence under section 1 of the Modern Slavery Act was received but was abandoned by the applicant and is now closed.</p><p> </p><p>3 applications for leave to appeal against sentence under section 2 of the Modern Slavery Act have been received. Of those, 1 is still pending and 2 have lapsed after leave to appeal was refused.</p><p> </p><p>Additionally, the Attorney General referred 1 sentence under section 2 of the Modern Slavery Act to the Court of Appeal for review under the Unduly Lenient Sentence scheme; the appeal was allowed and the sentence increased. And there was 1 prosecution appeal which confirmed the Crown Court ruling and the defendant was acquitted.</p> answering member printed Lord Keen of Elie grouped question UIN HL7595 HL7596 HL7597 HL7598 HL7599 question first answered 22/05/2018 15:30:41 answering member 4538 label Biography information for Lord Keen of Elie
tabling member	4197 label Biography information for Baroness Doocey

511840

registered interest
date	13/04/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the database created by the Access to Medical Treatments (Innovation) Act 2016 is intended to supersede the Medicines and Healthcare products Regulatory Agency’s hierarchy for the use of unlicensed medicines.
tabling member printed	Baroness Finlay of Llandaff
uin	HL7600
answer	answer is ministerial correction date of answer 26/04/2016 answer text <p>The database will not supersede the Medicines and Healthcare products Regulatory Agency’s (MHRA) guidance on the hierarchy for the use of unlicensed medicines, which is set out in the MHRA’s ‘Guidance Note 14’. The Access to Medical Treatments (Innovation) Act 2016 seeks to facilitate access to innovative medical treatments including the off-label use of medicines and the use of unlicensed medicines, such as in schemes like the Early Access to Medicines Scheme (EAMS). The Act provides for the establishment of a database of innovative medical treatments, which doctors can access to search for innovative treatments in schemes like the EAMS, including unlicensed or off-label medicines for which there is evidence that a patient might benefit. Where appropriate they can also search for clinical trials that are underway and discuss their findings with their patients to establish if they would benefit from being part of a clinical trial. There will be a full consultation on the database in due course.</p><p> </p><p> </p><p> </p> answering member printed Lord Prior of Brampton question first answered 26/04/2016 16:18:46 answering member 127 label Biography information for Lord Prior of Brampton attachment 1 file name Guide - supply_of_unlicensed_medicinal_products__specials.pdf title MHRA Guidance Note 14
tabling member	3609 label Biography information for Baroness Finlay of Llandaff